Claris life sciences ... Is it gud buy now ?

Time horizon : 5 years ...please share your views...

 

I googled it but couldnt get adequate info ... So posted here... If u knw pls share ji... This forum seems to be excellent...

 

I am awaiting mam..!

 

Claris is in news .. Wonder whether if its a buy .. Wait watch and see the developments keenly...


Cadila Healthcare to acquire Claris Lifesciences for Rs 3,400 crore
https://economictimes.indiatimes.com/articleshow/47363956.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

Attached is a report by Sunidhi Securities on Claris Lifescriencs about a month old

 

Claris lif science : Positive point : cadila health care deal in future.....last quarter resut thunderous 50% profit....new injectible buisness..... please share ur view ......

and please share view on NCC....even rakesh jhunujunawala also have stake in NCC..... my NCC price is 98

 

Claris management has guided for 30 to 35% growth and it's a strong player in generic injectibles pharma business. Stock looks undervalued for this kind of growth, views of members invited.

 

target price of ` 412 at a P/E of 1 2 x on FY17E..... Why such a low PE?

 

@Mr Pathak.Thiss fellow seems to have chronic problem of developing a business- he does it efficiently-and selling whole or part of it. He has already done it twice earlier and he intends to sell again a part to cadila. Earlier this sold a well run company by the name synthico or plethico,then about two years back he sold a well run infusion division to japanise pharma company and now he intends to sell again a part to Cadila.why does he do it? To reduce debt. ?But some experts have doubt on this issue. His integrity is not above suspicion .But this fellow has a knack of starting and and developing a pharma business well.

 

PE Investor Carlyle which held 11% had exited Claris Lifesciences earlier in this year.
Now, other FIIs have increased their stake in Claris Lifesciences from 13.97% as at June 30, 2015 to 17.72% as at Sept 30, 2015 which means increase of 27%. So market confidence in this stock appears to be slowly coming back. May be when Claris posts better business performance as guided by management and secures USFDA approvals that company has applied for its products, Claris Lifesciences will pick up momentum

 

Quick info on Claris:
They are into generic injectables space...now injectables are pretty difficult to manufacture....thus leaves it vulnerable to FDA inspection wrath....but if it gets its act together on compliance it can work wonders...because their is a real shortage of generic injectables in the regulated markets.. another blockbuster drug propofol is going off patent and claris will be one of the only manufacturers of propofol in injectables......
Propofol has a huge market share this i got to know from Neuland Laboratories who are planning to manufacture propofol api themselves in solid form......

so could be a great opportunity...
disc: invested

 

@Srouta Mukherjee ,@kharb ,,@elegantly_wasted

You must be aware of latest news about claris althogh it is in my holdings,baught@200 round six months back and intend to exit soon.I baught this stock on just my lucky intution,not on insight.

 

My Shilpa Medicare is doing good. Huge gains are there. I have big lot

 

Have not been tracking this one. Shilpa, agree with @Srouta Mukherjee. Good quarterly results and trend likely to continue.

 

My intention is to draw your attention on the integrity of management, while making investment,which is in my view lacking in this company,yet I invested ignoring my own opinion,hoping for change in intrgrity. I had invested for long term. My mistake! Lesson learnt.

 

Congratulation. How big is your bat?What percent of your portfolio?